Finance

Lists
APVO:NASDAQ
Aptevo Therapeutics Inc
$2.73
0.00%
(0.00) 1D
Aug 20, 9:31:24 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APVO...
Open
$2.74
High
$2.91
Low
$2.73
Mkt. cap
4.99M
Avg. vol.
39.66K
Volume
839.00
52-wk high
$48.78
52-wk low
$2.60
EPS
-$204.04
Beta
1.66
Shares outstanding
1.80M
No. of employees
33
Open
$2.74
High
$2.91
Low
$2.73
Mkt. cap
4.99M
Avg. vol.
39.66K
Volume
839.00
52-wk high
$48.78
52-wk low
$2.60
EPS
-$204.04
Beta
1.66
Shares outstanding
1.80M
No. of employees
33
News stories
From web sources and news partners
About Aptevo Therapeutics Inc
CEO-
Employees33
Founded2016
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteaptevotherapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to APVO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for APVO in the last 3 months
Highest
Current $2.73
$21.00 (+669.23%)
Average
$21.00 (+669.23%)
Lowest
$21.00 (+669.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
$21.00
+669.2%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.04M
3.54M
3.92M
3.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.57M
2.46M
2.91M
2.75M
Operating expense
7.61M
6.00M
6.84M
6.44M
Total operating expenses
7.61M
6.00M
6.84M
6.44M
Operating income
-7.61M
-6.00M
-6.84M
-6.44M
Other non operating income
61.00K
190.00K
140.00K
87.00K
EBT including unusual items
-7.55M
-5.81M
-6.70M
-6.36M
EBT excluding unusual items
-7.55M
-5.81M
-6.70M
-6.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.55M
-5.81M
-6.70M
-6.36M
Net profit margin
-
-
-
-
Earnings per share
-40.14
-
-6.41
-5.31
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.56M
-5.92M
-6.80M
-6.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps